Clearstead Trust, LLC Abb Vie Inc. Transaction History

Clearstead Trust, LLC

$372 Million
Q3 2024

A detailed history of Clearstead Trust, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clearstead Trust, LLC holds 12,218 shares of ABBV stock, worth $2.15 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

12,218

Previous 12,769 4.32%

Holding current value

$2.15 Million

Previous $2.19 Million 10.14%

% of portfolio

0.65%

Previous 0.61%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $90,275 - $109,830	-551 Reduced 4.32%	12,218 $2.41 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $204,322 - $238,603	-1,320 Reduced 9.37%	12,769 $2.19 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $164,934 - $187,927	-1,032 Reduced 6.82%	14,089 $2.57 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $277,126 - $312,109	-2,014 Reduced 11.75%	15,121 $2.34 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $2,938 - $3,402	-22 Reduced 0.13%	17,135 $2.55 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $76,325 - $94,982	576 Added 3.47%	17,157 $2.31 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $82,716 - $95,260	-572 Reduced 3.33%	16,581 $2.64 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $52,419 - $62,864	379 Added 2.26%	17,153 $2.77 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $2.08 Million - $2.38 Million	15,491 Added 1207.4%	16,774 $2.25 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $10,294 - $12,772	-78 Reduced 5.73%	1,283 $208,000
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $65,648 - $74,521	617 Added 82.93%	1,361 $147,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $78,276 - $87,204	744 New	744 $84,000
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $76,111 - $83,789	-744 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $4,039 - $5,054	-56 Reduced 7.0%	744 $66,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $91,950 - $108,221	-1,192 Reduced 59.84%	800 $65,000
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $186,711 - $207,564	-2,100 Reduced 51.32%	1,992 $188,000
Q2 2018 Aug 20, 2018	BUY	$89.78 - $106.23 $178,841 - $211,610	1,992 Added 94.86%	4,092 $379,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $33,767 - $45,218	-367 Reduced 14.88%	2,100 $199,000
Q2 2017 Aug 21, 2017	BUY	N/A	2,467	2,467 $179,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.

Account

Clearstead Trust, LLC Abb Vie Inc. Transaction History